Comment on US trade representative support of the temporary waiver of intellectual property for COVID-19 vaccines
Search Polity
Note: Search is limited to the most recent 250 articles. To access earlier articles, click Advanced Search and set an earlier date range.
To search for a term containing the '&' symbol, click Advanced Search and use the 'search headings' and/or 'in first paragraph' options.
With...
Clear Search
Sponsored by
Sponsored by
The Fix the Patent Laws campaign welcomes the announcement that the Biden-Harris Administration supports the temporary waiver of intellectual property protections for COVID-19 vaccines.
“This decision is as result of massive global solidarity and mobilisation by activists around the world, who have been fighting for equitable access for COVID-19 vaccines for all. While we commend this decision, it is important the waiver applies to all COVID-19 medical tools, including treatment and diagnostics, and not just vaccines,” says Umunyana Rugege, Executive Director of SECTION27.